| Mrs Shellagh R Marshall-young, CAS II | |
|
812 W Town And Country Rd, Orange, CA 92868-4712 | |
| (714) 547-6494 | |
| (714) 547-9990 |
| Full Name | Mrs Shellagh R Marshall-young |
|---|---|
| Gender | Male |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 812 W Town And Country Rd, Orange, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013290253 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 01-040566 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Shellagh R Marshall-young, CAS II 812 W. Town And Country Rd, Orange, CA 92868-4712 Ph: (171) 454-7649 | Mrs Shellagh R Marshall-young, CAS II 812 W Town And Country Rd, Orange, CA 92868-4712 Ph: (714) 547-6494 |
News Archive
Competitive Technologies, Inc. announced today that the Walter Reed Army Medical Center in Washington, D.C., has joined the growing list of organizations that will treat pain patients with CTT's Calmare Pain Therapy Treatment, as authorized by the Surgeon General of the U.S. Army and Commanding General of the U.S. Army Medical Command.
The presence of the human high-risk papillomavirus in the diagnosis of invasive cervical cancer is linked to a greatly improved prognosis compared with if high-risk HPV cannot be identified in the tumor, researchers at Karolinska Institutet in Sweden report in the scientific journal PLOS Medicine.
YM BioSciences Inc., announced that the FDA has advised the Company that it may now enroll patients at US clinical sites into two ongoing randomized, double-blind Phase II trials of its lead product, nimotuzumab. One of the two trials is in non-small-cell lung cancer (NSCLC) patients who are ineligible for curative treatment and being treated palliatively and the other in patients with brain metastases from NSCLC. Current NSCLC palliative treatment and treatment for brain metastases is radiation alone.
Medicaid managed-care plans reported an average ratio of one primary-care provider for every 584 beneficiaries, according to a recent survey. The newly released results of a February survey from the member plans of the Association for Community Affiliated Plans reported that among the 25 responding health plans the ratio ranged from one primary-care provider for every 53 plan enrollees to 1 provider for each 2,000 patients.
› Verified 8 days ago
Evelyn Brit Tran, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1717 W Orangewood Ave Ste I, Orange, CA 92868 Phone: 714-712-8349 | |
Gilbert Diallo Madison, SUDCC III-CS Counselor Medicare: Not Enrolled in Medicare Practice Location: 705 W La Veta Ave Ste 208, Orange, CA 92868 Phone: 714-532-9295 Fax: 714-532-9291 | |
Elena Louise Edwards, CADCA Counselor Medicare: Not Enrolled in Medicare Practice Location: 812 W Town And Country Rd, Orange, CA 92868 Phone: 714-547-6494 Fax: 714-547-9990 | |
Nuvia Rodriguez, Counselor Medicare: Not Enrolled in Medicare Practice Location: 401 S Tustin St, Orange, CA 92866 Phone: 714-289-3936 Fax: 714-289-3938 | |
Ken Sangboem Kim, Counselor Medicare: Not Enrolled in Medicare Practice Location: 265 S Anita Dr, Orange, CA 92868 Phone: 949-439-6109 | |
Kandace Plantier, Counselor Medicare: Not Enrolled in Medicare Practice Location: 265 S Anita Dr Ste 101, Orange, CA 92868 Phone: 949-749-2500 | |
Tyler James Allen, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1855 W Katella Ave Ste 150, Orange, CA 92867 Phone: 714-399-3480 |